Immunogenetics of Prostate Cancer: A Still Unexplored Field of Study

References

• Balkwill F , MantovaniA . Inflammation and cancer: back to Virchow?Lancet Lond. Engl.357 ( 9255 ), 539 – 545 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Lo Iacono M , ButtiglieroC , MonicaVet al. Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer . Oncotarget7 ( 12 ), 14394 – 14404 ( 2016 ).
   PubMedGoogle Scholar
• Sun T , LeeG-SM , OhWKet al. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population . Clin. Cancer Res.16 ( 21 ), 5244 – 5251 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lavender NA , RogersEN , YeyeoduSet al. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer . BMC Med. Genomics5 , 11 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lin H-Y , AmankwahEK , TsengT-S , QuX , ChenD-T , ParkJY . SNP–SNP interaction network in angiogenesis genes associated with prostate cancer aggressiveness . PLoS ONE8 ( 4 ), e59688 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kearns JT , LapinB , WangEet al. Associations between iCOGS single nucleotide polymorphisms and upgrading in both surgical and active surveillance cohorts of men with prostate cancer . Eur. Urol.69 ( 2 ), 223 – 228 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Alvarez-Cubero MJ , Martinez-GonzalezLJ , SaizMet al. Prognostic role of genetic biomarkers in clinical progression of prostate cancer . Exp. Mol. Med.47 , e176 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Alvarez-Cubero MJ , EntralaC , Fernandez-RosadoFet al. Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer . Prostate Cancer Prostatic Dis.15 ( 2 ), 144 – 149 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Meyer MS , PenneyKL , StarkJRet al. Genetic variation in RNASEL associated with prostate cancer risk and progression . Carcinogenesis31 ( 9 ), 1597 – 1603 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Winchester DA , TillC , GoodmanPJet al. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial . Prostate77 ( 8 ), 908 – 919 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Sun T , MaryLG-S , OhWKet al. Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort . Clin. Cancer Res.17 ( 6 ), 1546 – 1552 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zambra FMB , BiolchiV , BrumIS , ChiesJAB . CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer . Hum. Immunol.74 ( 8 ), 1003 – 1008 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kucukgergin C , IsmanFK , CakmakogluB , SanliO , SeckinS . Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer . DNA Cell Biol.31 ( 8 ), 1418 – 1424 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zambra FMB , BiolchiV , de CerqueiraCCS , BrumIS , CastelliEC , ChiesJaB . Immunogenetics of prostate cancer and benign hyperplasia – the potential use of an HLA-G variant as a tag SNP for prostate cancer risk . HLA87 ( 2 ), 79 – 88 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Stingl Jankovic K , HudolinT , KastelanZ , ZunecR , GrubicZ . The possible role of the tumor necrosis factor polymorphisms and human leucocyte antigens in the development of prostate cancer . Int. J. Immunogenet.43 ( 3 ), 143 – 150 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Shui IM , StarkJR , PenneyKLet al. Genetic variation in the Toll-like receptor 4 and prostate cancer incidence and mortality . Prostate72 ( 2 ), 209 – 216 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kazma R , MeffordJA , ChengIet al. Association of the innate immunity and inflammation pathway with advanced prostate cancer risk . PLoS ONE7 ( 12 ), e51680 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• De Langhe S , De RuyckK , OstPet al. Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene . Int. J. Radiat. Oncol. Biol. Phys.85 ( 2 ), 393 – 399 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kerns SL , StockRG , StoneNNet al. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer . Radiother. Oncol.107 ( 3 ), 372 – 376 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Barnett GC , ColesCE , ElliottRMet al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study . Lancet Oncol.13 ( 1 ), 65 – 77 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fachal L , Gómez-CaamañoA , Sánchez-GarcíaMet al. TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients . Radiother. Oncol.103 ( 2 ), 206 – 209 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Langsenlehner T , ThurnerE-M , RennerW , GergerA , KappKS , LangsenlehnerU . Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy . Strahlenther. Onkol.190 ( 4 ), 364 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ahmed M , DorlingL , KernsSet al. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity . Br. J. Cancer.114 ( 10 ), 1165 – 1174 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Jim HSL , ParkJY , Permuth-WeyJet al. Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings . Brain. Behav. Immun.26 ( 7 ), 1030 – 1036 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bachmann HS , HeukampLC , SchmitzKJet al. Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma . Int. J. Cancer129 ( 10 ), 2390 – 2399 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Renner W , LangsenlehnerU , Krenn-PilkoS , EderP , LangsenlehnerT . BCL2 genotypes and prostate cancer survival . Strahlenther. Onkol.193 ( 6 ), 466 – 471 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Dluzniewski PJ , WangM-H , ZhengSLet al. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence . Cancer Epidemiol. Biomark. Prev.21 ( 10 ), 1774 – 1782 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang BY , RiskaSM , MahoneyDWet al. Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer . BJU Int.119 ( 3 ), 489 – 495 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Miles FL , RaoJ-Y , EckhertC , ChangS-C , PantuckA , ZhangZ-F . Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients . Int. J. Clin. Exp. Med.8 ( 7 ), 11470 – 11476 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Solini A , SimeonV , DerosaLet al. Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients . Oncotarget6 ( 30 ), 28743 – 28754 ( 2015 ).
   PubMedGoogle Scholar
• Schoenfeld JD , MargalitDN , KasperzykJLet al. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer . Clin. Cancer Res.19 ( 6 ), 1612 – 1619 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lin DW , FitzGeraldLM , FuRet al. Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality . Cancer Epidemiol. Biomark. Prev.20 ( 9 ), 1928 – 1936 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Karyadi DM , ZhaoS , HeQet al. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families . Int. J. Cancer.136 ( 9 ), 2166 – 2171 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Perez CA , ChenH , ShyrYet al. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer . J. Urol.183 ( 5 ), 2062 – 2069 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jaboin JJ , HwangM , LopaterZet al. The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer . Int. J. Radiat. Oncol. Biol. Phys.79 ( 5 ), 1330 – 1335 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Morote J , Del AmoJ , BorqueAet al. Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms . J. Urol.184 ( 2 ), 506 – 511 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Nückel H , FreyUH , BauMet al. Association of a novel regulatory polymorphism (–938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia . Blood109 ( 1 ), 290 – 297 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Pham M-HT , BonelloGB , CastiblancoJet al. The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance . PLoS ONE7 ( 11 ), e49498 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rovin BH , LuL , SaxenaR . A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression . Biochem. Biophys. Res. Commun.259 ( 2 ), 344 – 348 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Nakayama EE , TanakaY , NagaiY , IwamotoA , ShiodaT . A CCR2-V64I polymorphism affects stability of CCR2A isoform . AIDS Lond. Engl.18 ( 5 ), 729 – 738 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Huang Y , PaxtonWA , WolinskySMet al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression . Nat. Med.2 ( 11 ), 1240 – 1243 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Shen J , ArnettDK , ParnellLDet al. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study . Diabetes Care31 ( 5 ), 910 – 915 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Miller DT , ZeeRYL , Suk DanikJet al. Association of common CRP gene variants with CRP levels and cardiovascular events . Ann. Hum. Genet.69 ( Pt 6 ), 623 – 638 ( 2005 ).
   PubMedGoogle Scholar
• Lange LA , CarlsonCS , HindorffLAet al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events . JAMA296 ( 22 ), 2703 – 2711 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Turner DM , WilliamsDM , SankaranD , LazarusM , SinnottPJ , HutchinsonIV . An investigation of polymorphism in the interleukin-10 gene promoter . Eur. J. Immunogenet.24 ( 1 ), 1 – 8 ( 1997 ).
   PubMedGoogle Scholar
• Lind H , HaugenA , ZienolddinyS . Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells . Cytokine38 ( 1 ), 43 – 48 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vargas-Alarcón G , Cruz-LópezM , ValladaresAet al. The interleukin-1β-511 T>C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients . Immunol. Lett.168 ( 1 ), 7 – 12 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liu S , LiT , LiuJ . Interleukin-4 rs2243250 polymorphism is associated with asthma among Caucasians and related to atopic asthma . Cytokine59 ( 2 ), 364 – 369 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Noss EH , NguyenHN , ChangSK , WattsGFM , BrennerMB . Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types . Proc. Natl Acad. Sci. USA112 ( 48 ), 14948 – 14953 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Fang Y , KongB , YangQ , MaD , QuX . MDM2 309 polymorphism is associated with missed abortion . Hum. Reprod.24 ( 6 ), 1346 – 1349 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Jormsjö S , WhatlingC , WalterDH , ZeiherAM , HamstenA , ErikssonP . Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients . Arterioscler. Thromb. Vasc. Biol.21 ( 11 ), 1834 – 1839 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Zhang M , HanZ , YanZet al. Genetic variants of the class A scavenger receptor gene are associated with essential hypertension in Chinese . J. Thorac. Dis.7 ( 11 ), 1891 – 1897 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Gu BJ , ZhangW , WorthingtonRAet al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor . J. Biol. Chem.276 ( 14 ), 11135 – 11142 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Cabrini G , FalzoniS , ForchapSLet al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes . J. Immunol.175 ( 1 ), 82 – 89 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Casey G , NevillePJ , PlummerSJet al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases . Nat. Genet.32 ( 4 ), 581 – 583 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Datta A , MazumderMHH , ChowdhuryAS , HasanMA . Functional and structural consequences of damaging single nucleotide polymorphisms in human prostate cancer predisposition gene RNASEL . BioMed. Res. Int. 2015 , 271458 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Xiang Y , WangZ , MurakamiJet al. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′,5′-oligoadenylates . Cancer Res.63 ( 20 ), 6795 – 6801 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Grainger DJ , HeathcoteK , ChianoMet al. Genetic control of the circulating concentration of transforming growth factor type beta1 . Hum. Mol. Genet.8 ( 1 ), 93 – 97 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Silverman ES , PalmerLJ , SubramaniamVet al. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma . Am. J. Respir. Crit. Care Med.169 ( 2 ), 214 – 219 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zheng W , YanC , WangXet al. The TGFB1 functional polymorphism rs1800469 and susceptibility to atrial fibrillation in two Chinese Han populations . PLoS ONE8 ( 12 ), e83033 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sato K , YoshimuraA , KanekoTet al. A single nucleotide polymorphism in 3′-untranslated region contributes to the regulation of Toll-like receptor 4 translation . J. Biol. Chem.287 ( 30 ), 25163 – 25172 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wilson AG , SymonsJA , McDowellTL , McDevittHO , DuffGW . Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation . Proc. Natl Acad. Sci. USA94 ( 7 ), 3195 – 3199 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Dumont P , LeuJI-J , Della PietraAC , GeorgeDL , MurphyM . The codon 72 polymorphic variants of p53 have markedly different apoptotic potential . Nat. Genet.33 ( 3 ), 357 – 365 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bergamaschi D , SamuelsY , SullivanAet al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53 . Nat. Genet.38 ( 10 ), 1133 – 1141 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Siddique M , SabapathyK . Trp53-dependent DNA-repair is affected by the codon 72 polymorphism . Oncogene.25 ( 25 ), 3489 – 3500 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• D’Amico AV , WhittingtonR , MalkowiczSBet al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer . JAMA280 ( 11 ), 969 – 974 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Eklund CM , TammelaTLJ , SchleutkerJ , HurmeM . C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk . Br. J. Cancer100 ( 12 ), 1846 – 1851 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• De Marzo AM , MarchiVL , EpsteinJI , NelsonWG . Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis . Am. J. Pathol.155 ( 6 ), 1985 – 1992 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Cai Q , TangY , ZhangMet al. TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis . tumor Biol.35 ( 1 ), 667 – 673 ( 2014 ).
   PubMedGoogle Scholar
• Men T , YuC , WangDet al. The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies . Oncotarget8 ( 28 ), 45994 – 46005 ( 2017 ).
   PubMedGoogle Scholar
• Stevens VL , HsingAW , TalbotJTet al. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk . Int. J. Cancer.123 ( 11 ), 2644 – 2650 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mandal RK , AgrawalT , MittalRD . Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer . tumor Biol.36 ( 1 ), 375 – 381 ( 2015 ).
   PubMedGoogle Scholar
• Hawkins PT , StephensLR . PI3K signalling in inflammation . Biochim. Biophys. Acta1851 ( 6 ), 882 – 897 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Xue L , HanX , LiuRet al. MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer . Oncotarget7 ( 22 ), 31825 – 31831 ( 2016 ).
   PubMedGoogle Scholar
• Zhang Q , LiuS , ParajuliKRet al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition . Oncogene36 ( 5 ), 687 – 699 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Fu H , HeY , QiLet al. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells . Cancer Lett.403 , 260 – 270 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Carpten J , NupponenN , IsaacsSet al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 . Nat. Genet.30 ( 2 ), 181 – 184 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Dayal S , ZhouJ , ManivannanPet al. RNase L suppresses androgen receptor signaling, cell migration and matrix metalloproteinase activity in prostate cancer cells . Int. J. Mol. Sci.18 ( 3 ), pii: E529 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Xu J , ZhengSL , HawkinsGAet al. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22–23 . Am. J. Hum. Genet.69 ( 2 ), 341 – 350 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• McDermott DH , YangQ , KathiresanSet al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study . Circulation112 ( 8 ), 1113 – 1120 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hudson LE , AllenRL . Leukocyte Ig-like receptors – a model for MHC Class I disease associations . Front. Immunol.7 , 281 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Shiina T , HosomichiK , InokoH , KulskiJK . The HLA genomic loci map: expression, interaction, diversity and disease . J. Hum. Genet.54 ( 1 ), 15 – 39 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Takeda K , KaishoT , AkiraS . Toll-like receptors . Annu. Rev. Immunol.21 , 335 – 376 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Weng P-H , HuangY-L , PageJHet al. Polymorphisms of an innate immune gene, Toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis . PLoS ONE9 ( 10 ), e110569 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lips IM , DehnadH , van GilsCH , Boeken KrugerAE , van der HeideUA , van VulpenM . High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients . Radiat. Oncol. Lond. Engl.3 , 15 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Donovan JL , HamdyFC , LaneJAet al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer . N. Engl. J. Med.375 ( 15 ), 1425 – 1437 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ , LevinEJ , HuntMet al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer . Int. J. Radiat. Oncol. Biol. Phys.70 ( 4 ), 1124 – 1129 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Herskind C , TalbotCJ , KernsSL , VeldwijkMR , RosensteinBS , WestCML . Radiogenomics: a systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Cancer Lett.382 ( 1 ), 95 – 109 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Oh SA , LiMO . TGF-β: guardian of T cell function . J. Immunol.191 ( 8 ), 3973 – 3979 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Diener KR , NeedEF , BuchananG , HayballJD . TGF-β signalling and immunity in prostate tumorigenesis . Expert Opin. Ther. Targets14 ( 2 ), 179 – 192 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Peters CA , StockRG , CesarettiJAet al. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy . Int. J. Radiat. Oncol. Biol. Phys.70 ( 3 ), 752 – 759 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Alsbeih G , El-SebaieM , Al-HarbiN , Al-HadyanK , ShoukriM , Al-RajhiN . SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers . Radiat. Oncol. Lond. Engl.8 , 125 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guerra JLL , GomezD , WeiQet al. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer . Radiother. Oncol.105 ( 3 ), 299 – 304 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• He J , DengL , NaF , XueJ , GaoH , LuY . The association between TGF-β1 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis . PLoS ONE9 ( 3 ), e91100 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Terrazzino S , La MattinaP , GambaroGet al. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients . Int. J. Radiat. Oncol. Biol. Phys.83 ( 2 ), 504 – 511 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Storey DJ , McLarenDB , AtkinsonMAet al. Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy . Ann. Oncol.23 ( 6 ), 1542 – 1549 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bellido T , JilkaRL , BoyceBFet al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor . J. Clin. Invest.95 ( 6 ), 2886 – 2895 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Gonzalez BD , JimHSL , Booth-JonesMet al. Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison . J. Clin. Oncol.33 ( 18 ), 2021 – 2027 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Paller CJ , AntonarakisES . Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions . Clin. Adv. Hematol. Oncol.11 ( 1 ), 14 – 23 ( 2013 ).
   PubMedGoogle Scholar
• Gabrilovich DI , NagarajS . Myeloid-derived suppressor cells as regulators of the immune system . Nat. Rev. Immunol.9 ( 3 ), 162 – 174 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Colotta F , AllavenaP , SicaA , GarlandaC , MantovaniA . Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability . Carcinogenesis30 ( 7 ), 1073 – 1081 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Setrerrahmane S , XuH . Tumor-related interleukins: old validated targets for new anti-cancer drug development . Mol. Cancer16 ( 1 ), 153 ( 2017 ).
   PubMedGoogle Scholar
• Ianni M , PorcelliniE , CarboneIet al. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer . Prostate Cancer Prostatic Dis.16 ( 1 ), 56 – 61 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Koestler DC , UssetJ , ChristensenBCet al. DNA methylation-derived neutrophil-to-lymphocyte ratio: an epigenetic tool to explore cancer inflammation and outcomes . Cancer Epidemiol. Biomarkers Prev.26 ( 3 ), 328 – 338 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Shiao SL , ChuGC-Y , ChungLWK . Regulation of prostate cancer progression by the tumor microenvironment . Cancer Lett.380 ( 1 ), 340 – 348 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Sun Q , ZhaoX , LiuXet al. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1 . Prostate74 ( 16 ), 1613 – 1621 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Galon J , MlecnikB , BindeaGet al. Towards the introduction of the ‘immunoscore’ in the classification of malignant tumors . J. Pathol.232 ( 2 ), 199 – 209 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Galon J , FoxBA , BifulcoCBet al. Immunoscore and immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015 . J. Transl. Med.14 , 273 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Buttigliero C , PisanoC , TucciMet al. Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel . Acta Oncol. Stockh. Swed.56 ( 4 ), 555 – 562 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Sidaway P . Prostate cancer: platelet-to-lymphocyte ratio predicts prostate cancer prognosis . Nat. Rev. Urol.12 ( 5 ), 238 ( 2015 ).
   PubMedGoogle Scholar
• Thurner E-M , Krenn-PilkoS , LangsenlehnerUet al. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy . Eur. J. Cancer51 ( 5 ), 610 – 619 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cao J , ZhuX , ZhaoX , LiX-F , XuR . Neutrophil-to-lymphocyte ratio predicts PSA response and prognosis in prostate cancer: a systematic review and meta-analysis . PLoS ONE11 ( 7 ), e0158770 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Besbes S , MirshahiM , PocardM , BillardC . New dimension in therapeutic targeting of BCL-2 family proteins . Oncotarget6 ( 15 ), 12862 – 12871 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bachmann HS , OtterbachF , CalliesRet al. The AA genotype of the regulatory BCL2 promoter polymorphism (938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients . Clin. Cancer Res.13 ( 19 ), 5790 – 5797 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lehnerdt GF , FranzP , BankfalviAet al. The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma . Ann. Oncol.20 ( 6 ), 1094 – 1099 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hoang DT , IczkowskiKA , KilariD , SeeW , NevalainenMT . Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: opportunities for therapeutic targeting from multiple angles . Oncotarget8 ( 2 ), 3724 – 3745 ( 2017 ).
   PubMedGoogle Scholar
• Sabat R , GrützG , WarszawskaKet al. Biology of interleukin-10 . Cytokine Growth Factor Rev.21 ( 5 ), 331 – 344 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Landskron G , De la FuenteM , ThuwajitP , ThuwajitC , HermosoMA . Chronic inflammation and cytokines in the tumor microenvironment . J. Immunol. Res.2014 , 149185 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gupta M , HanJJ , StensonMet al. Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation . Blood119 ( 12 ), 2844 – 2853 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Berg DJ , ZhangJ , LauricellaDM , MooreSA . Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production . J. Immunol.166 ( 4 ), 2674 – 2680 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Lee C-H , PaoJ-B , LuT-Let al. prognostic value of prostaglandin-endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy . Int. J. Med. Sci.13 ( 9 ), 696 – 700 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Mazhar A , MazharA , JamilFet al. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women . Mol. Med. Rep.14 ( 4 ), 3443 – 3451 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F , ApetohL , TesniereAet al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors . Nat. Med.15 ( 10 ), 1170 – 1178 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Qiu Y , LiW-H , ZhangH-Q , LiuY , TianX-X , FangW-G . P2X7 mediates ATP-driven invasiveness in prostate cancer cells . PLoS ONE9 ( 12 ), e114371 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Guo B , FuS , ZhangJ , LiuB , LiZ . Targeting inflammasome/IL-1 pathways for cancer immunotherapy . Sci. Rep.6 , 36107 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kolb R , LiuG-H , JanowskiAM , SutterwalaFS , ZhangW . Inflammasomes in cancer: a double-edged sword . Protein Cell.5 ( 1 ), 12 – 20 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hegemann M , StenzlA , BedkeJ , ChiKN , BlackPC , TodenhöferT . Liquid biopsy: ready to guide therapy in advanced prostate cancer?BJU Int.118 ( 6 ), 855 – 863 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Liu W , YinB , WangXet al. Circulating tumor cells in prostate cancer: precision diagnosis and therapy . Oncol. Lett.14 ( 2 ), 1223 – 1232 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Soekmadji C , CorcoranNM , OleinikovaIet al. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer . Prostate77 ( 14 ), 1416 – 1423 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Feng J , GangF , LiXet al. Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen . Int. Urol. Nephrol.45 ( 4 ), 1023 – 1028 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Souza MF de , KuasneH , Barros-FilhoM de Cet al. Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer . PLoS ONE12 ( 9 ), e0184094 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Cochetti G , PoliG , GuelfiG , BoniA , EgidiMG , MeariniE . Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role . Oncotargets Ther.9 , 7545 – 7553 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Orozco G , GohCL , Al OlamaAAet al. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis . BJU Int.111 ( 7 ), 1148 – 1155 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kang BJ , JeunM , JangGHet al. Diagnosis of prostate cancer via nanotechnological approach . Int. J. Nanomedicine10 , 6555 – 6569 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liu Y , SolomonM , AchilefuS . Perspectives and potential applications of nanomedicine in breast and prostate cancer . Med. Res. Rev.33 ( 1 ), 3 – 32 ( 2013 ).
   PubMed Web of Science ®Google Scholar